Should I Buy CBUS? CBUS 2026 Analysis

Should You Buy Cibus Inc (CBUS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

2.080

1 Day change

-7.14%

52 Week Range

3.400

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now for an impatient entry: price is stretched/overbought (RSI 6 = 80) and sitting above the first resistance zone, which skews risk toward a near-term pullback.
Technical trend is bullish, but upside from here looks more like a short-term momentum/scalp setup than a fresh, favorable risk-reward buy.
Fundamentals are deteriorating sharply (2025/Q3 revenue and earnings down materially YoY), and there are no fresh news catalysts to justify chasing.
Options positioning is extremely call-skewed, but volumes are tiny—sentiment is speculative rather than broadly confirmed.

Technical Analysis

Trend: Bullish structure (SMA_5 > SMA_20 > SMA_200) suggests an uptrend is in place.
Momentum: MACD histogram is positive (0.0338) and expanding, supporting continued momentum.
Overbought condition: RSI_6 at 80.203 signals overbought; historically this increases odds of a pause or pullback.
Key levels: Pivot 1.888; Support S1 1.537 (then S2 1.319). Resistance R1 2.239 (already exceeded in pre-market at ~2.29), next resistance R2 2.457.
Pattern-based odds: Similar-pattern stats imply modest upside next day/week (+1.07% / +1.54%) but negative skew over a month (-2.41%), aligning with “late-stage” momentum risk.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning: Open interest put/call ratio = 0.03 (very call-heavy), indicating bullish/speculative positioning.
Activity: Today’s option volume is extremely low (2 contracts total; puts 0), so sentiment signal lacks depth.
Volatility: Implied vol (30d) ~200.72 vs historical vol ~94.95; IV percentile 81.2 suggests options are expensive and pricing large moves.
Skew/flow interpretation: Call dominance can support momentum, but with thin volume it may reflect limited participation rather than strong institutional conviction.

Technical Summary

Sell

Buy

Positive Catalysts

- Price trend is currently bullish (moving averages aligned; MACD expanding), which can attract short-term momentum buyers.
- Options open interest is heavily call-skewed (bullish positioning), potentially supportive in the very near term.
- Pre-market is green (+0.44%) with broader market mildly positive (S&P 500 +0.16%), not fighting macro tape today.

Neutral/Negative Catalysts

- No news in the recent week: lack of event-driven catalysts makes chasing an overbought move less attractive.
- Overbought RSI increases probability of a near-term pullback or consolidation.
- Options imply very high expected movement (IV ~200%); combined with thin volume, this points to speculative, unstable price action.
- Similar-pattern forward stats show negative bias over the next month (-2.41%).

Financial Performance

Latest quarter: 2025/Q3.
Revenue: 615,000, down -63.11% YoY (sharp contraction).
Net income: -23,541,000, down -86.92% YoY (loss deepening materially).
EPS: -0.44, down -94.23% YoY (significant deterioration).
Gross margin: 100 (flat YoY), but margin data is less meaningful given the very low revenue base; overall growth trend is negative.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst rating and price target change data were not provided, so recent Wall Street upgrades/downgrades and target revisions cannot be confirmed from the dataset.
Pros typically cited by Wall Street (general): potential upside from innovation pipeline/optionalities in small-cap biotech/ag inputs.
Cons typically cited by Wall Street (supported by this data): weak/declining revenue base, large losses, and high uncertainty reflected in extreme implied volatility.

3 Analyst Rating

Wall Street analysts forecast CBUS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBUS is 18.67 USD with a low forecast of 15 USD and a high forecast of 25 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

Current: 2.240

Low

Averages

18.67

High

Current: 2.240

Low

Averages

18.67

High

Canaccord

Austin Moeller

Buy

downgrade

$18

AI Analysis

2025-05-12

Reason

Canaccord

Austin Moeller

Price Target

$18

AI Analysis

2025-05-12

downgrade

Buy

Reason

Canaccord analyst Austin Moeller lowered the firm's price target on Cibus to $17.50 from $18 and keeps a Buy rating on the shares. The firm noted Cibus is not yet generating meaningful commercial revenues at this point in the company's lifecycle. However, through contract research on behalf of customers relating to collaborative agreements for products and traits, the company has consistently generated some quarterly revenue in advance of major trait commercializations. Cibus' nearest-term revenue-generation opportunity continues is its sustainable ingredients biofragrance product pipeline.

HC Wainwright & Co.

Amit Dayal

Strong Buy

Reiterates

$25

2025-03-21

Reason

HC Wainwright & Co.

Amit Dayal

Price Target

$25

2025-03-21

Reiterates

Strong Buy

Reason

CBUS Should I Buy

CBUS Should I Buy

Should You Buy Cibus Inc (CBUS) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch